0001235802-23-000110.txt : 20231108
0001235802-23-000110.hdr.sgml : 20231108
20231108161625
ACCESSION NUMBER: 0001235802-23-000110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230804
FILED AS OF DATE: 20231108
DATE AS OF CHANGE: 20231108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STANKOVICH THOMAS
CENTRAL INDEX KEY: 0001181166
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37897
FILM NUMBER: 231388117
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReShape Lifesciences Inc.
CENTRAL INDEX KEY: 0001427570
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
BUSINESS PHONE: 949-429-6680
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
FORMER COMPANY:
FORMER CONFORMED NAME: OBALON THERAPEUTICS INC
DATE OF NAME CHANGE: 20080220
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2023-08-04
0
0001427570
ReShape Lifesciences Inc.
RSLS
0001181166
STANKOVICH THOMAS
1001 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Financial Officer
0
Common Stock, $0.001 par value per share
2023-08-04
4
S
0
108
1.43
D
23276
D
Common Stock, $0.001 par value per share
2023-08-24
4
S
0
39
1.42
D
23237
D
Common Stock, $0.001 par value per share
2023-09-01
4
S
0
118
0.89
D
23119
D
Common Stock, $0.001 par value per share
2023-10-11
4
S
0
39
0.93
D
23080
D
Common Stock, $0.001 par value per share
2023-10-25
4
S
0
131
0.27
D
22949
D
On July 22, 2021, Mr. Stankovich was awarded an aggregate of 7,455 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.
/s/ Thomas Stankovich
2023-11-08